I beg to differ on what is the most important event on the timeline.
Obviously FDA approval is the end game and without it you go nowhere (in the USA) however the most important event was statistically significant findings of drug efficacy in the pivot phase III trial. Confirmation that the drug actually works.
Now it’s ticking the boxes to make sure it gets commercialised and gets to the people in desperate need of it. They’re going to have to come up with a significant reason to deny these patients a treatment in an area without a current treatment.
No one here can really come up with one
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-3199
-
-
- There are more pages in this discussion • 8,278 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B |
Open | High | Low | Value | Volume |
$15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6044 | $15.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.57 | 1411 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1892 | 15.320 |
3 | 2996 | 15.300 |
1 | 1308 | 15.290 |
1 | 300 | 15.280 |
2 | 1892 | 15.270 |
Price($) | Vol. | No. |
---|---|---|
15.570 | 1411 | 2 |
15.620 | 2616 | 3 |
15.660 | 1892 | 1 |
15.680 | 1892 | 1 |
15.710 | 1892 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online